BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14708338)

  • 1. Composite outcomes in clinical trials: uses and problems.
    Carneiro AV
    Rev Port Cardiol; 2003 Oct; 22(10):1253-63. PubMed ID: 14708338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of the results of clinical trials: surrogate end points and composite end points.
    Gensini GF; Conti AA
    Minerva Med; 2004 Feb; 95(1):71-5. PubMed ID: 15041928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surrogate end point fallacies -- the urge for randomized trials with clinical endpoints].
    Mühlhauser I; Meyer G
    Psychother Psychosom Med Psychol; 2006 May; 56(5):193-201. PubMed ID: 16586306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized clinical trials: the meeting place of medical practice and clinical research.
    Hughes EG
    Semin Reprod Med; 2003 Feb; 21(1):55-64. PubMed ID: 12806560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging issues in randomised controlled trials.
    Nichol AD; Bailey M; Cooper DJ; ;
    Injury; 2010 Jul; 41 Suppl 1():S20-3. PubMed ID: 20413119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of studies of treatments for hand eczema-the EDEN hand eczema survey.
    Van Coevorden AM; Coenraads PJ; Svensson A; Bavinck JN; Diepgen TL; Naldi L; Elsner P; Williams HC;
    Br J Dermatol; 2004 Aug; 151(2):446-51. PubMed ID: 15327553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac disease outcomes in clinical trials.
    Carneiro AV; Costa J
    Rev Port Cardiol; 2002 Nov; 21(11):1349-60. PubMed ID: 12564085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The handsearching of 2 medical journals of Bahrain for reports of randomized controlled trials.
    Al-Hajeri AA; Fedorowicz Z; Amin FA; Eisinga A
    Saudi Med J; 2006 Apr; 27(4):526-30. PubMed ID: 16598332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite outcomes in randomized clinical trials: arguments for and against.
    Ross S
    Am J Obstet Gynecol; 2007 Feb; 196(2):119.e1-6. PubMed ID: 17306647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measures of association in clinical trials: definition and interpretation.
    Carneiro AV
    Rev Port Cardiol; 2003 Nov; 22(11):1393-401. PubMed ID: 14768494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new and rapid scoring system to assess the scientific evidence from clinical trials.
    Silber S
    J Interv Cardiol; 2006 Dec; 19(6):485-92. PubMed ID: 17107362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
    Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
    J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic evaluation of the quality of randomized controlled trials in diabetes.
    Montori VM; Wang YG; Alonso-Coello P; Bhagra S
    Diabetes Care; 2006 Aug; 29(8):1833-8. PubMed ID: 16873788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key issues in end point selection for heart failure trials: composite end points.
    Neaton JD; Gray G; Zuckerman BD; Konstam MA
    J Card Fail; 2005 Oct; 11(8):567-75. PubMed ID: 16230258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative outcome measures for pediatric clinical sepsis trials.
    Curley MA; Zimmerman JJ
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S150-6. PubMed ID: 15857550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Powering our way to the elusive side effect: a composite outcome 'basket' of predefined designated endpoints in each organ system should be included in all controlled trials.
    Tugwell P; Judd MG; Fries JF; Singh G; Wells GA
    J Clin Epidemiol; 2005 Aug; 58(8):785-90. PubMed ID: 16018913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is significant relevant? Validity and patient benefit of randomized controlled clinical trials on age-related macular degeneration.
    Joussen AM; Lehmacher W; Hilgers RD; Kirchhof B
    Surv Ophthalmol; 2007; 52(3):266-78. PubMed ID: 17472802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant conclusions from HIV clinical trials--an evaluation of efficacy endpoints.
    Hill A; Demasi R
    Antivir Ther; 2005; 10(3):367-74. PubMed ID: 15918328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.